Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Sabouret

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Life (Basel, Switzerland)|January 8, 2025
Defensive Medicine in an Emergency Department: The Overuse of High-Sensitivity Cardiac Troponin I TestingMohammed Hani Sayyad, Nir Levi, Sharon Bruoha, et al.
Minerva Cardiology and Angiology|November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectivesLuigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex PatientsLuigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation AgentsLuigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
Platelets|January 29, 2026
Immature platelet fraction as a prognostic marker in patients with pulmonary embolismAkiva Brin, Ranel Loutati, Ariella Tvito, et al.
Journal of Clinical Medicine|March 14, 2026
Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary SyndromeNelsa González-Aguado, Rafael Franco-Hita, Jose Ignacio Larrubia-Valle, et al.
Journal of Clinical Medicine|June 13, 2025
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary InterventionAntonio Capolongo, Vincenzo De Sio, Felice Gragnano, et al.
BMC Geriatrics|April 2, 2026
NSTEMI in the oldest-old: prognosis and impact of invasive management in patients ≥ 85 yearsAbed Qadan, Louay Taha, Mohammad Karmi, et al.
Annals of Medicine|June 30, 2025
Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR surveySilvia Oghina, Damien Legallois, Fabien Hyafil, et al.
Expert Review of Cardiovascular Therapy|August 8, 2025
Cangrelor in percutaneous coronary interventions: advances in evidence, clinical applications, and future directionsVincenzo De Sio, Felice Gragnano, Arturo Cesaro, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Life (Basel, Switzerland)|January 8, 2025
Defensive Medicine in an Emergency Department: The Overuse of High-Sensitivity Cardiac Troponin I TestingMohammed Hani Sayyad, Nir Levi, Sharon Bruoha, et al.
Minerva Cardiology and Angiology|November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectivesLuigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex PatientsLuigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation AgentsLuigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.
Platelets|January 29, 2026
Immature platelet fraction as a prognostic marker in patients with pulmonary embolismAkiva Brin, Ranel Loutati, Ariella Tvito, et al.
Journal of Clinical Medicine|March 14, 2026
Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary SyndromeNelsa González-Aguado, Rafael Franco-Hita, Jose Ignacio Larrubia-Valle, et al.
Journal of Clinical Medicine|June 13, 2025
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary InterventionAntonio Capolongo, Vincenzo De Sio, Felice Gragnano, et al.
BMC Geriatrics|April 2, 2026
NSTEMI in the oldest-old: prognosis and impact of invasive management in patients ≥ 85 yearsAbed Qadan, Louay Taha, Mohammad Karmi, et al.
Annals of Medicine|June 30, 2025
Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR surveySilvia Oghina, Damien Legallois, Fabien Hyafil, et al.
Expert Review of Cardiovascular Therapy|August 8, 2025
Cangrelor in percutaneous coronary interventions: advances in evidence, clinical applications, and future directionsVincenzo De Sio, Felice Gragnano, Arturo Cesaro, et al.
Pageof 14